Figure 7
From: MYBBP1A suppresses breast cancer tumorigenesis by enhancing the p53 dependent anoikis

MYBBP1A enhances p53 activation during anoikis. (A) Acetylation at lysine 382 residues of p53 induced under detached conditions requires MYBBP1A. MCF-7 cells were treated with siControl or siMYBBP1A for 48 h followed by culture under attached or detached conditions for 2 h. Cell lysates were analyzed by immunoblot using the indicated antibodies. (B) p53 recruitment to the Bax promoter under detached conditions requires MYBBP1A. MCF-7 cells were treated as shown in (A), and ChIP assay was performed using normal mouse IgG and anti-p53 antibodies. The p53-binding region of the Bax promoter was amplified and analyzed by RT–qPCR. (C) MYBBP1A translocates from the nucleolus to the nucleoplasm under detached conditions. MCF-7 cells were cultured under attached or detached conditions for 2 h, after which the localizations of MYBBP1A and p53 were visualized by immunofluorescence using anti-MYBBP1A and anti-p53 antibodies. (D) Endogenous MYBBP1A associates with p53 under detached conditions. MCF-7 cells were cultured under detached conditions for 2 h. The cell lysates were immunoprecipitated with normal rabbit IgG or anti-MYBBP1A antibodies and analyzed by immunoblot using antibodies against MYBBP1A and p53. Bars = mean + s.d. (n = 3).